Last reviewed · How we verify

NCT04581239

Effect of Active Versus Passive Lower Extremity Neural Mobilization in Lumber Radiculopathy

Completed NA Last updated 9 October 2020
What this trial tests

NA trial testing Active neural mobilization in Lumbar Radiculopathy in 24 participants. Completed in 30 January 2020.

Timeline
15 March 2019
Primary endpoint
20 December 2019
30 January 2020

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment24
Start date15 March 2019
Primary completion20 December 2019
Estimated completion30 January 2020
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 45 to 65, any sex, with Lumbar Radiculopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to find out the effects of active versus passive lower extremity neuralmobilizations combined with lumbar traction and lumbar mobilization in patients with lumbarradiculopathy. The study was conducted in shalamar hospital Lahore and was completed within 6 month of time duration. Sample size of twenty four patient consists of both male and female aged between 45 years to 65 years. Each group contain 12 patients. Group A received active neural mobilizations whereas group B received passive neural mobilization along with lumber traction and mobilization. Patients were re assessed at the end of 6 weeks through SLR , NPRS and ODI.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Lumbar Radiculopathy

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04581239.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing